Clinical Trial

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome
Trial Details
NCT Number NCT04217733
Lead Sponsor Tanta University
Conditions IBS - Irritable Bowel Syndrome
Enrollment 60 participants
Start Date 2019-11-01
Primary Completion 2030-12-01 (estimated)
Study Completion 2030-12-30 (estimated)
Updated on ClinicalTrials.gov 2020-01-03